Bortezomib-pinanediol,
205393-22-2,
Bortezomib Pinanediol Ester,
Bortezomib pinanediol,
BORTEZOMIBPINANEDIOLESTER,
(1R)-(1S,2S,3R,5S)-Pinanediol-N-(N-pyrazinylphenylalaninoyl)-1-amino-3-methyl-butane-1-boronate,
N-((S)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide,
N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide,
CHEMBL501663,
SCHEMBL8098845,
C29H39BN4O4,
HZCSTPSWJFWZHP-GQABWHEGSA-N,
MFCD11973734,
AKOS015841786,
AKOS015950824,
ZINC169952278,
DS-4785,
AC-22608,
SC-22247,
FT-0603949,
ST24046242,
Y0262,
393B222,
(1alpha,5alpha)-2,6,6-Trimethyl-2alpha,3alpha-[[(R)-1-[N-(pyrazine-2-ylcarbonyl)-L-phenylalanylamino]-3-methylbutyl]boranediylbisoxy]bicyclo[3.1.1]heptane,
N-{(1R)-3-Methyl-1-[(3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methano-1,3,2-benzodioxaborol-2-yl]butyl}-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide,
ACN-044348,